Youth Suicide Prevention Research Act

House Bill

H.R. 2630

119th Congress

Youth Suicide Prevention Research Act

In Committee

Introduced:Sep 26, 2025

Primary Sponsor

Laura Gillen

Representative

Democratic

NY-4

Cosponsors

235

Quick Stats

Policy Area

Health

Summary

This bill would require health insurance plans to allow exceptions to their medication step-therapy protocols in certain cases, such as if the required treatment is ineffective or likely to cause an adverse reaction. It sets timelines for plans to respond to requests for these exceptions.

Latest Action

Referred to the House Committee on Education and the Workforce.

SponsorLaura Gillen (D-NY)

Introduced9/26/2025

StatusReferred to the House Committee on Science, Space, and Technology.

ChamberHouse

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

Youth Suicide Prevention Research Act

This bill would require health insurance plans to allow exceptions to their medication step-therapy protocols in certain cases, such as if the required treatment is ineffective or likely to cause an adverse reaction. It sets timelines for plans to respond to r

Community Breakdown

Pass

0%

Fail

0%

0 predictions

This bill would require health insurance plans to allow exceptions to their medication step-therapy protocols in certain cases, such as if the required treatment is ineffective or likely to cause an adverse reaction. It sets timelines for plans to respond to requests for these exceptions.

Bill Number: 2630
Sponsor: Laura Gillen (D-NY)
Introduced: 9/26/2025
Status: Referred to the House Committee on Science, Space, and Technology.
Policy Area: Health

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: Youth Suicide Prevention Research Act
Bill Number: 2630
Sponsor: Laura Gillen (D-NY)
Status: Referred to the House Committee on Science, Space, and Technology.
Introduced: 9/26/2025
Summary: This bill would require health insurance plans to allow exceptions to their medication step-therapy protocols in certain cases, such as if the required treatment is ineffective or likely to cause an adverse reaction. It sets timelines for plans to respond to requests for these exceptions.

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

This bill would require health insurance plans to allow exceptions to their medication step-therapy protocols in certain cases, such as if the required treatment is ineffective or likely to cause an adverse reaction. It sets timelines for plans to respond to requests for these exceptions.

Last updated: 12/29/2025

Official Summary

Congressional Research Service summary

Safe Step Act This bill requires a group health plan to establish an exception to medication step-therapy protocol in specified cases. A medication step-therapy protocol establishes a specific sequence in which prescription drugs are covered by a group health plan or a health insurance issuer.  A request for such an exception to the protocol must be granted if (1) an otherwise required treatment has been ineffective, (2) such treatment is expected to be ineffective and delaying effective treatment would lead to irreversible consequences, (3) such treatment will cause or is likely to cause an adverse reaction to the individual, (4) such treatment is expected to prevent the individual from performing daily activities or occupational responsibilities, (5) the individual is stable based on the prescription drugs already selected, or (6) there are other circumstances as determined by the Employee Benefits Security Administration. The bill requires a group health plan to implement and make readily available a clear process for an individual to request an exception to the protocol, including required information and criteria for granting an exception. The bill further specifies timelines under which plans must respond to such requests.

Key Points

Main provisions of the bill

Allows exceptions to medication step-therapy protocols in specified cases, such as if the required treatment is ineffective or harmful
Requires health plans to have a clear process for individuals to request these exceptions
Sets timelines for health plans to respond to exception requests

How This Impacts Americans

Potential effects on citizens and communities

This bill would affect individuals who are enrolled in group health insurance plans and have been denied coverage for a medication their doctor prescribed due to the plan's step-therapy protocol. If passed, these patients would have an easier path to get the treatment their doctor believes is best for their health.

Policy Areas

Primary Policy Area

Health

Related Subjects

Drug therapy

Employee benefits and pensions

Health care costs and insurance

Health care coverage and access

Prescription drugs

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

2630, 119th Congress (2025). "Youth Suicide Prevention Research Act". Source: Voter's Right Platform. https://votersright.org/bills/118-hr-2630

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.

Related Bills in Health

HR 3021

Empowering Patient Choice of Medical Care Act

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means

HR 2111

To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.

Referred to the House Committee on Energy and Commerce.

HR 2884

Anti-Racism in Public Health Act of 2025

Referred to the House Committee on Energy and Commerce.

S 1406

SOAR Act of 2025

Read twice and referred to the Committee on Finance.